195 related articles for article (PubMed ID: 23226780)
1. Methylation of tumor suppressor genes in ovarian cancer.
Ozdemir F; Altinisik J; Karateke A; Coksuer H; Buyru N
Exp Ther Med; 2012 Dec; 4(6):1092-1096. PubMed ID: 23226780
[TBL] [Abstract][Full Text] [Related]
2. Delineating an epigenetic continuum for initiation, transformation and progression to breast cancer.
Chen KM; Stephen JK; Raju U; Worsham MJ
Cancers (Basel); 2011 Jun; 3(2):1580-92. PubMed ID: 21776373
[TBL] [Abstract][Full Text] [Related]
3. Comparison of methylation profiling in cancerous and their corresponding normal tissues from korean patients with breast cancer.
Jung EJ; Kim IS; Lee EY; Kang JE; Lee SM; Kim DC; Kim JY; Park ST
Ann Lab Med; 2013 Nov; 33(6):431-40. PubMed ID: 24205493
[TBL] [Abstract][Full Text] [Related]
4. Distinct promotor methylation at tumor suppressive genes in ovarian cancer stromal progenitor cells and ovarian cancer and its clinical implication.
Ho CM; Yen TL; Chien TY; Huang SH
Am J Cancer Res; 2022; 12(11):5325-5341. PubMed ID: 36504889
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic effects of
Xia L; Zhang W; Gao L
Biomarkers; 2019 Nov; 24(7):700-711. PubMed ID: 31382782
[No Abstract] [Full Text] [Related]
6. DNA methylation in thyroid tumorigenesis.
Stephen JK; Chitale D; Narra V; Chen KM; Sawhney R; Worsham MJ
Cancers (Basel); 2011 Jun; 3(2):1732-43. PubMed ID: 21738852
[TBL] [Abstract][Full Text] [Related]
7. DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach.
Casadio V; Molinari C; Calistri D; Tebaldi M; Gunelli R; Serra L; Falcini F; Zingaretti C; Silvestrini R; Amadori D; Zoli W
J Exp Clin Cancer Res; 2013 Nov; 32(1):94. PubMed ID: 24252461
[TBL] [Abstract][Full Text] [Related]
8. DNA hypermethylation profiles in squamous cell carcinoma of the vulva.
Stephen JK; Chen KM; Raitanen M; Grénman S; Worsham MJ
Int J Gynecol Pathol; 2009 Jan; 28(1):63-75. PubMed ID: 19047905
[TBL] [Abstract][Full Text] [Related]
9. Methylation analysis of tumour suppressor genes in ovarian cancer using MS-MLPA.
Chmelařová M; Křepinská E; Spaček J; Laco J; Nekvindová J; Palička V
Folia Biol (Praha); 2012; 58(6):246-50. PubMed ID: 23438850
[TBL] [Abstract][Full Text] [Related]
10. Utility of MS-MLPA in DNA methylation profiling in primary laryngeal squamous cell carcinoma.
López F; Sampedro T; Llorente JL; Domínguez F; Hermsen M; Suárez C; Alvarez-Marcos C
Oral Oncol; 2014 Apr; 50(4):291-7. PubMed ID: 24444674
[TBL] [Abstract][Full Text] [Related]
11. Methylation profiles in breast cancer.
Buyru N; Altinisik J; Ozdemir F; Demokan S; Dalay N
Cancer Invest; 2009 Mar; 27(3):307-12. PubMed ID: 19194828
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
[TBL] [Abstract][Full Text] [Related]
13. Importance of Tumour Suppressor Gene Methylation in Sinonasal Carcinomas.
Chmelařová M; Sirák I; Mžik M; Sieglová K; Vošmiková H; Dundr P; Němejcová K; Michálek J; Vošmik M; Palička V; Laco J
Folia Biol (Praha); 2016; 62(3):110-9. PubMed ID: 27516190
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation assessment as a prognostic factor in invasive breast cancer using methylation-specific multiplex ligation dependent probe amplification.
Shakeri H; Gharesouran J; Fakhrjou A; Esfahani A; Mohaddes Ardebili SM
EXCLI J; 2016; 15():11-20. PubMed ID: 27065772
[TBL] [Abstract][Full Text] [Related]
15. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.
Kontic M; Stojsic J; Jovanovic D; Bunjevacki V; Ognjanovic S; Kuriger J; Puumala S; Nelson HH
Clin Lung Cancer; 2012 Jul; 13(4):297-303. PubMed ID: 22169480
[TBL] [Abstract][Full Text] [Related]
17. Methylation of tumor suppressor genes is related with copy number aberrations in breast cancer.
Murria R; Palanca S; de Juan I; Egoavil C; Alenda C; García-Casado Z; Juan MJ; Sánchez AB; Santaballa A; Chirivella I; Segura Á; Hervás D; Llop M; Barragán E; Bolufer P
Am J Cancer Res; 2015; 5(1):375-85. PubMed ID: 25628946
[TBL] [Abstract][Full Text] [Related]
18. Consistent DNA hypermethylation patterns in laryngeal papillomas.
Stephen JK; Chen KM; Shah V; Schweitzer VG; Gardner G; Benninger MS; Worsham MJ
Int J Head Neck Surg; 2010 May; 1(2):69-77. PubMed ID: 21603083
[TBL] [Abstract][Full Text] [Related]
19. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of tumor suppressor genes in patients with refractory anemia with ring sideroblasts.
Valencia A; Cervera J; Such E; Ibañez M; Gómez I; Luna I; Senent L; Oltra S; Sanz MA; Sanz GF
Leuk Res; 2011 Apr; 35(4):479-83. PubMed ID: 20864173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
